News

RetinAI US Inc. (RetinAI) and Fundación Ver Salud (FVS) are pleased to jointly announce that LuxIA ®, their co-developed innovative AI algorithm for Diabetic Retinopathy (DR) screening, has ...
In a significant move to strengthen eye health services, Sightsavers has provided Holy Family Hospital Rawalpindi with ...
The NHS has approved Mainline Instruments' iCare DRSPlus Confocal Fundus Imaging System for use in the national diabetic eye ...
ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”) recently announced U.S. FDA approval of its innovative yield enhancement production process. This innovative process has demonstrated an ...
A multidisciplinary team at Barraquer Eye Hospital UAE has successfully treated a pregnant patient suffering from advanced ...
The following is a summary of “Racial disparities in patients with proliferative diabetic retinopathy treated with pars plana vitrectomy in an underserved population,” published in the April 2025 ...
The company announced 27 abstracts at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting ...
The primary driver of this market expansion is the rising demand for vitrectomy procedures, a critical surgical intervention for treating a range of eye conditions, particularly those affecting the ...
A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The ...
New research reveals UBX1325's potential to significantly improve vision in diabetic macular edema patients, offering hope ...
While many studies have focused on generating high-fidelity synthetic images for beneficial applications, very few have ...
Regarding eye care, selecting the Best eye hospital in Patna is absolutely essential for preserving ideal eyesight and ...